4.5 Review

Increasing O-GlcNAc levels: An overview of small-molecule inhibitors of O-GlcNAcase

Journal

BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
Volume 1800, Issue 2, Pages 107-121

Publisher

ELSEVIER
DOI: 10.1016/j.bbagen.2009.07.028

Keywords

O-GlcNAc; Nucleocytoplasmic glycosylation; Glycoprotein; O-GlcNAcase; OGA; Enzyme inhibitor; Glycoside hydrolase; Substrate-assisted catalysis

Funding

  1. Natural Sciences and Engineering Research Council of Canada (NSERC)
  2. Canadian Institutes of Health Research (CIHR)
  3. Michael Smith Foundation of Health Research (MSFHR)

Ask authors/readers for more resources

The O-GlcNAc modification is found on many nucleocytoplasmic proteins.-he dynamic nature of O-GlcNAc, which in some ways is reminiscent of phosphorylation, has enabled investigators to modulate the stoichiometry of O-GlcNAc on proteins in order to study its function Although several genetic and pharmacological methods for manipulating O-GlcNAc levels have been described, one of the most direct approaches of increasing global O-GlcNAc levels is by using small-molecule inhibitors of O-GlcNAcase (OGA). As the interest in increasing O-GlcNAc levels has grown, so too has the number of OGA inhibitors. This review provides an overview of the available methods of increasing O-GlcNAc levels, with a special emphasis on inhibition of OGA by small molecules. Known inhibitors of OGA are discussed with particular attention on those most suitable for cell-based biological studies. Several examples in which OGA inhibitors have been used to study the functional role of the O-GlcNAc modification in biological systems are discussed, highlighting the pros and cons of different inhibitors. (C) 2008 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available